Motus GI Holdings ROE 2016-2023 | MOTS
Current and historical return on equity (ROE) values for Motus GI Holdings (MOTS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Motus GI Holdings ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2023-12-31 | $-0.01B | $0.00B | 5200.00% |
| 2023-09-30 | $-0.01B | $-0.00B | 5600.00% |
| 2023-06-30 | $-0.02B | $-0.00B | -3200.00% |
| 2023-03-31 | $-0.02B | $-0.00B | -1028.57% |
| 2022-12-31 | $-0.02B | $0.00B | -447.06% |
| 2022-09-30 | $-0.02B | $0.00B | -333.33% |
| 2022-06-30 | $-0.02B | $0.00B | -216.22% |
| 2022-03-31 | $-0.02B | $0.01B | -156.86% |
| 2021-12-31 | $-0.03B | $0.01B | -170.49% |
| 2021-09-30 | $-0.03B | $0.01B | -161.29% |
| 2021-06-30 | $-0.02B | $0.02B | -152.38% |
| 2021-03-31 | $-0.02B | $0.02B | -170.37% |
| 2020-12-31 | $-0.02B | $0.01B | -158.33% |
| 2020-09-30 | $-0.02B | $0.02B | -152.73% |
| 2020-06-30 | $-0.02B | $0.01B | -137.50% |
| 2020-03-31 | $-0.02B | $0.01B | -152.38% |
| 2019-12-31 | $-0.02B | $0.02B | -146.03% |
| 2019-09-30 | $-0.02B | $0.02B | -143.75% |
| 2019-06-30 | $-0.02B | $0.01B | -187.76% |
| 2019-03-31 | $-0.02B | $0.01B | -155.56% |
| 2018-12-31 | $-0.02B | $0.02B | -151.72% |
| 2018-09-30 | $-0.02B | $0.01B | -177.78% |
| 2018-06-30 | $-0.02B | $0.01B | -160.00% |
| 2018-03-31 | $-0.02B | $0.02B | -212.50% |
| 2017-12-31 | $-0.01B | $0.01B | -346.67% |
| 2017-06-30 | $-0.01B | $0.00B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.000B |
| Motus GI Holdings, Inc. is a medical technology company. It focuses on the development and commercialization of the Pure-Vu(R) System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company also operates through subsidiaries in the U.S. and Israel. Motus GI Holdings, Inc. is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.555B | 21.44 |
| Inspire Medical Systems (INSP) | United States | $6.945B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.488B | 0.00 |
| Axonics (AXNX) | United States | $3.415B | 0.00 |
| 10x Genomics (TXG) | United States | $3.330B | 0.00 |
| Enovis (ENOV) | United States | $3.062B | 23.26 |
| Azenta (AZTA) | United States | $2.825B | 230.23 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.719B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.550B | 0.00 |
| Privia Health (PRVA) | United States | $2.145B | 95.16 |
| Schrodinger (SDGR) | United States | $1.756B | 0.00 |
| Omnicell (OMCL) | United States | $1.278B | 31.27 |
| Phreesia (PHR) | United States | $1.224B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.832B | 0.00 |
| Standard BioTools (LAB) | United States | $0.731B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.609B | 0.00 |
| Talkspace (TALK) | United States | $0.530B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.327B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.324B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.315B | 0.00 |
| Pulmonx (LUNG) | United States | $0.289B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.160B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.159B | 0.00 |
| American Well (AMWL) | United States | $0.158B | 0.00 |
| Augmedix (AUGX) | United States | $0.146B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.133B | 0.00 |
| TruBridge (TBRG) | United States | $0.121B | 5.17 |
| Outset Medical (OM) | United States | $0.120B | 0.00 |
| 111 (YI) | China | $0.085B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.076B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.064B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.043B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.021B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.019B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Biotricity (BTCY) | United States | $0.013B | 0.00 |
| Centogene (CNTG) | Germany | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |